Aptevo Therapeutics Inc. Shareholders' Equity
Aptevo Therapeutics Inc. (APVO) had Shareholders' Equity of $6.04 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $11.61M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $17.38M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $17.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $6.04M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.61M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $17.38M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $17.39M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $6.52M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$1.47M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $4.75M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $4.42M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $4.46M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $6.10M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $12.22M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $14.72M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $16.25M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $23.26M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $17.97M 10-K · filed 2025-02-14 | |
| 2022-09-30 | $15.76M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $23.05M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$5.88M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $1.22M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $7.29M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $13.88M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $10.50M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $16.59M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $2.20M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $8.65M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $15.15M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $11.84M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $19.75M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $26.20M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $39.13M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | $30.41M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $44.00M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $56.03M 10-Q · filed 2019-11-07 | $56.03M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $68.36M 10-Q · filed 2019-08-09 | $68.36M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $82.03M 10-K · filed 2020-03-25 | |
| 2017-09-30 | $90.31M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $51.42M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $61.49M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $50.57M 10-K · filed 2019-03-18 | |
| 2016-09-30 | $63.75M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $97.20M 10-K · filed 2017-03-31 | |
| 2016-03-31 | $89.86M 10-K · filed 2017-03-31 | |
| 2015-12-31 | $88.62M 10-K · filed 2018-03-13 | |
| 2014-12-31 | $94.61M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |